Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Goodwill & Intangibles (2019 - 2025)

Historic Goodwill & Intangibles for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to $1.5 million.

  • Volitionrx's Goodwill & Intangibles rose 469.18% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 469.18%. This contributed to the annual value of $1.4 million for FY2024, which is 556973.96% up from last year.
  • Latest data reveals that Volitionrx reported Goodwill & Intangibles of $1.5 million as of Q3 2025, which was up 469.18% from $1.5 million recorded in Q2 2025.
  • Volitionrx's 5-year Goodwill & Intangibles high stood at $1.5 million for Q2 2025, and its period low was $23886.0 during Q4 2023.
  • Moreover, its 5-year median value for Goodwill & Intangibles was $228915.0 (2021), whereas its average is $635652.6.
  • Per our database at Business Quant, Volitionrx's Goodwill & Intangibles crashed by 7838.47% in 2023 and then surged by 556973.96% in 2024.
  • Volitionrx's Goodwill & Intangibles (Quarter) stood at $216876.0 in 2021, then crashed by 49.05% to $110505.0 in 2022, then crashed by 78.38% to $23886.0 in 2023, then skyrocketed by 5569.74% to $1.4 million in 2024, then grew by 11.73% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $1.5 million for Q2 2025, and $1.4 million during Q1 2025.